April 16, 2018

Global Cancer Initiative Launched. Consortium Organized

Initiated by a global think tank, Klosters Institute, the objective is to create a consortium committed to fostering collaboration. Research to assessing connectivity the global cancer ecosystem and published in a Cancer Impact Guide targeted at family offices, foundations and impact investors.  Initiated by a global think tank, Klosters Institute, […]
November 3, 2017

The Case for Investing in Orphan Drugs

Investing in biotech companies developing therapeutics seems like a natural decision for physicians and other healthcare providers. One area that should particularly be considered are “orphan drugs” – products being developed for a rare disease. A disease is classified as a “rare disease” if the patient population in the United […]
August 24, 2017

Buying Spree: Chinese FDI in Western healthcare companies

In 2016, Chinese companies invested more than $44B in the United States. The amount of investment has been growing steadily since 2000, increasing substantially each coming year. Over the last 16 years, there were more than 110 deals between Chinese investors and U.S. healthcare companies totaling $3.9 billion, 20 of […]
July 31, 2017

Tinnitus: When the World is Too Loud

Derived from the Latin verb tinnire (to ring), the term tinnitus describes the conscious perception of an auditory sensation in the absence of a corresponding external stimulus. Tinnitus is a common medical condition that can be debilitating, often leading to hearing loss, ototoxic medication, head injury, and depression. Tinnitus is […]
June 3, 2017

Marcum Microcap Conference Overview. Healthcare Companies to Watch

The 6th Marcum Microcap conference is fast approaching on June 15 and 16 in NYC. This growing and increasingly significant conference will take up the Grand Hyatt Hotel to accommodate the estimated 2000 investors and industry professionals who are expected. Healthcare again dominates the conference with 59 companies in that […]
May 11, 2017

Electroceuticals vs. Pharmaceuticals: Can electricity replace opioids?

The increased awareness of the devastating impact of opiate addiction has increased attention towards new approaches to treating chronic pain. New over-the-counter products are entering the market and Big Pharma along with the NIH are entering the game. Glaxo SmithKline has invested $50 million to develop a new pain management […]
April 12, 2017

New Drugs in Opiate Addiction Battle

The New York City Police Department reported a startling statistic last week: a 38% increase in fatal opioid overdoses in the city last year. Approximately 1,300 fatalities – more than homicide (335) and traffic collision (220) deaths combined – were recorded, mainly as a result of heroin and painkiller overdoses. […]
March 28, 2017

Pain and Opiates: Is the Opioid Crisis a Self-Inflicted Wound? (First in a Series)

Approximately 33,000 Americans in 2015 died from opiates. 22,000 of those were involving prescription opioids the same equivalent to about 62 deaths a day. These numbers are skyrocketing compared to previous years.  It is an epidemic. Can it be stopped? (Picture from CDC, https://www.cdc.gov/drugoverdose/data/analysis.html) The number of Americans who died […]
March 12, 2017

The Case for a Healthcare Futures Market

BY:  BRETT JOHNSON, EDITOR-IN-CHIEF As politicians and the public wrestle with redesigning the nation’s healthcare system, all parties are faced with the twin realities of an aging population and rising health costs. The cost of healthcare in the United States, which has risen inexorably for the last 50 years, is […]
January 29, 2017

Undervalued Microcaps: OneMed Research announces new healthcare report

OneMed Research announced the introduction of a research process and report to identify the most undervalued microcap healthcare companies. The purpose is to provide recognition to exceptional companies that go unnoticed. The model will use a panel of fund managers and experts to rate firms and recognize those they view as […]
January 5, 2017

Advances in Medicine: Opportunities for Investors

BY: BRETT JOHNSON, EDITOR-IN-CHIEF The pace of innovation in healthcare continues at a seemingly accelerated rate which makes the discovery of promising companies less challenging. But success is elusive and requires true and disruptive innovations combined with capable and committed management teams.  Below we’ve highlighted some of our best ideas […]
December 17, 2016

The Uber for Investment Bankers? Wall Street veteran Weild creates new business model for independent investment bankers

BY: BRETT JOHNSON, EDITOR-IN-CHIEF “We want to put the joy back into investment banking,” says David Weild IV, the former NASDAQ vice chairman and head of Equity and Corporate Finance at Prudential. Just as Uber relies on a network of independent drivers, who each earn a percentage of every ride they […]
November 26, 2016

Solving the Pain and Addiction Epidemic

  BY: BRETT JOHNSON, EDITOR-IN-CHIEF The U.S. Surgeon General published a report this week, entitled “Facing Addiction in America: The Surgeon General’s Report on Alcohol, Drugs and Health”. This Report takes a comprehensive look at the national addiction epidemic, covering the misuse of alcohol, prescription drugs, and other substances, and bringing […]
November 20, 2016

Ploughing Under Diamonds in the Rough

BY: MICHAEL WEICKERT,  Ph.D. CONTRIBUTING EDITOR At this year’s BIO International Convention one panel discussed “The Newest Bright Shiny Thing — The Challenge Of True Innovation”.  Working as I do with drug and device startups on the cutting edge of medical innovation, the panel’s thoughts were of great interest to […]
October 30, 2016

Industry Leaders Outlook on the Future of Healthcare

BY: BRETT JOHNSON, EDITOR-IN-CHIEF “Value-driven” vs. “volume-driven” was the theme of a discussion between top management of the country’s important healthcare institutions. Leaders of Mayo Clinic, United Healthcare, IBM and Medtronic addressed over 2,000 medical technology executives at the 10th Annual AdvaMed conference in Minneapolis, giving their outlook on the future of […]
October 9, 2016

Finding the Needle in the Haystack: Eight keys to getting funded

BY: BRETT JOHNSON, EDITOR-IN-CHIEF It takes time to raise capital. Irrespective of how terrific or groundbreaking your medical technology, raising capital is a long and difficult road. It almost never goes fast. By analogy, despite, extraordinary advances in technology, it still takes nine months to make a baby. Raising money is […]